| Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ … M Suárez‐Calvet, TK Karikari, NJ Ashton, J Lantero Rodriguez, ... EMBO molecular medicine 12 (12), e12921, 2020 | 218 | 2020 |
| Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum AL Benedet, M Milà-Alomà, A Vrillon, NJ Ashton, TA Pascoal, F Lussier, ... JAMA neurology 78 (12), 1471-1483, 2021 | 203 | 2021 |
| Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease M Milà-Alomà, NJ Ashton, M Shekari, G Salvadó, P Ortiz-Romero, ... Nature medicine 28 (9), 1797-1801, 2022 | 139 | 2022 |
| Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum M Milà‐Alomà, G Salvadó, JD Gispert, N Vilor‐Tejedor, O Grau‐Rivera, ... Alzheimer's & Dementia 16 (10), 1358-1371, 2020 | 131 | 2020 |
| Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers G Salvadó, JL Molinuevo, A Brugulat-Serrat, C Falcon, O Grau-Rivera, ... Alzheimer's research & therapy 11, 1-12, 2019 | 96 | 2019 |
| Association between insomnia and cognitive performance, gray matter volume, and white matter microstructure in cognitively unimpaired adults O Grau-Rivera, G Operto, C Falcón, G Sánchez-Benavides, R Cacciaglia, ... Alzheimer's research & therapy 12, 1-14, 2020 | 63 | 2020 |
| Spatial patterns of white matter hyperintensities associated with Alzheimer’s disease risk factors in a cognitively healthy middle-aged cohort G Salvadó, A Brugulat-Serrat, CH Sudre, O Grau-Rivera, M Suárez-Calvet, ... Alzheimer's research & therapy 11, 1-14, 2019 | 61 | 2019 |
| Multitracer model for staging cortical amyloid deposition using PET imaging LE Collij, F Heeman, G Salvadó, S Ingala, D Altomare, A de Wilde, ... Neurology 95 (11), e1538-e1553, 2020 | 55 | 2020 |
| Prediction of longitudinal cognitive decline in preclinical Alzheimer disease using plasma biomarkers N Mattsson-Carlgren, G Salvadó, NJ Ashton, P Tideman, E Stomrud, ... JAMA neurology 80 (4), 360-369, 2023 | 53 | 2023 |
| Patterns of white matter hyperintensities associated with cognition in middle-aged cognitively healthy individuals A Brugulat-Serrat, G Salvadó, CH Sudre, O Grau-Rivera, M Suárez-Calvet, ... Brain imaging and behavior 14, 2012-2023, 2020 | 48 | 2020 |
| CSF synaptic biomarkers in the preclinical stage of Alzheimer disease and their association with MRI and PET: a cross-sectional study M Milà-Alomà, A Brinkmalm, NJ Ashton, H Kvartsberg, M Shekari, ... Neurology 97 (21), e2065-e2078, 2021 | 43 | 2021 |
| Associations between air pollution and biomarkers of Alzheimer’s disease in cognitively unimpaired individuals S Alemany, M Crous-Bou, N Vilor-Tejedor, M Mila-Aloma, ... Environment international 157, 106864, 2021 | 41 | 2021 |
| Quantification of amyloid PET for future clinical use: a state-of-the-art review HG Pemberton, LE Collij, F Heeman, A Bollack, M Shekari, G Salvadó, ... European Journal of Nuclear Medicine and Molecular Imaging 49 (10), 3508-3528, 2022 | 40 | 2022 |
| Spatial-temporal patterns of β-amyloid accumulation: a subtype and stage inference model analysis LE Collij, G Salvadó, V Wottschel, SE Mastenbroek, P Schoenmakers, ... Neurology 98 (17), e1692-e1703, 2022 | 37 | 2022 |
| Episodic memory and executive functions in cognitively healthy individuals display distinct neuroanatomical correlates which are differentially modulated by aging R Cacciaglia, JL Molinuevo, G Sánchez‐Benavides, C Falcón, N Gramunt, ... Human brain mapping 39 (11), 4565-4579, 2018 | 33 | 2018 |
| Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads G Salvadó, R Ossenkoppele, NJ Ashton, TG Beach, GE Serrano, ... EMBO Molecular Medicine 15 (5), e17123, 2023 | 32 | 2023 |
| Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia G Salvadó, MJ Grothe, C Groot, A Moscoso, M Schöll, JD Gispert, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 2212-2224, 2021 | 31 | 2021 |
| P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease J Lantero‐Rodriguez, A Snellman, AL Benedet, M Milà‐Alomà, ... EMBO Molecular Medicine 13 (12), e15098, 2021 | 29 | 2021 |
| White matter hyperintensities mediate gray matter volume and processing speed relationship in cognitively unimpaired participants A Brugulat‐Serrat, G Salvadó, G Operto, R Cacciaglia, CH Sudre, ... Human Brain Mapping 41 (5), 1309-1322, 2020 | 29 | 2020 |
| Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent LE Collij, G Salvadó, M Shekari, I Lopes Alves, J Reimand, AM Wink, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 2169-2182, 2021 | 26 | 2021 |
